beta
OASM
Oasmia Pharmaceutical AB
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Oasmia Pharmaceutical AB is a pharmaceutical company. It develops a new generation of drugs within human and veterinary oncology. It has two approved products: Paclical and Paccal Vet-CA1.
Market Cap: 73.5 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.oasmia.com
Shares Outstanding: 58.8 Million
Float: 58.8 Million
Dividend: 0.0 (0.0%)
Beta: 2.31678
Sector: Healthcare
Industry: Drug Manufacturers
Ethical Flags
Longest drawdown: 583 trading days
From: 2016-05-25 To: 2018-09-25
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|